Roche Holding Aktiengesellschaft operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft with three other
pharmaceutical manufacturers in Europe:
Novartis AG
(2018
sales of 51.94 billion Swiss Francs [US$53.88 billion]
of which 66%
was Innovative Medicines),
GlaxoSmithKline plc
of the United Kingdom
(£30.82 billion [US$40.24 billion]
of which 56%
was Pharmaceuticals), and
Bayer AG
which is
based in Germany
(39.59 billion Euro [US$43.94 billion]
of which 42%
was Pharmaceuticals & Biological Products).
Sales Analysis.
Roche Holding Aktiengesellschaft reported sales of 56.85 billion Swiss Francs (US$58.97 billion)
for the
year ending
December of 2018.
This
represents
an
increase of 6.7%
versus 2017, when the company's sales were 53.30 billion Swiss Francs.
Sales at Roche Holding Aktiengesellschaft have increased during each of the previous five years
(and since 2013, sales have increased a total of 22%).
Sales of Pharmaceuticals saw an increase
of
6.7% in 2018, from
41.22 billion Swiss Francs to 43.97 billion Swiss Francs.